Yahoo Finance

$2.3 Bn Viral Vector, Non-Viral Vector and Gene Therapy Manufacturing Markets, 2035 - Viral Vectors Gain Traction with 30+ Approvals and 200+ Gene Therapies in U.S. Clinical Trials

Dublin, April 01, 2025 (GLOBE NEWSWIRE) -- The "Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market Industry Trends and Global Forecasts to 2035, by Scale ...

AWS claims 90% vector cost savings with S3 Vectors GA, calls it 'complementary' - analysts split on what it means for vector databases

Despite the aggressive cost claims and dramatic scale improvements, AWS is positioning S3 Vectors as a complementary storage ...
FMIBlog

U.S. Viral Vector Development Market Forecast 2025–2035: Trends and Growth Insights

The market is projected to scale rapidly—from USD 1,029 million in 2025 to USD 5,765 million by 2035—representing a swift ...
Mena FN

$2.3 Bn Viral Vector, Non-Viral Vector And Gene Therapy Manufacturing Markets, 2035 - Viral Vectors Gain Traction With 30+ Approvals And 200+ Gene Therapies In U.S. Clinical Trials

(MENAFN- GlobeNewsWire - Nasdaq) As drug developers invest more in these innovative therapies, the market for viral vector manufacturing, non-viral vector manufacturing and gene therapy manufacturing ...